MTND5P31: A Drug Target / Disease Biomarker (G100873267)

Target Name: MTND5P31

NCBI ID: G100873267

MTND5P31

Other Name(s): Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 pseudogene 31 | MT-ND5 pseudogene 31

MTND5P31: A Drug Target / Disease Biomarker

MTND5P31 is a protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. The protein is known for its role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

One of the unique features of MTND5P31 is its structure. It is a transmembrane protein, which means that it spans the cell membrane and is found in both the cytoplasm and the nucleus. This allows it to interact with a wide range of molecules on both sides of the membrane, including those in the brain.

In addition to its unique structure, MTND5P31 is also known for its role in several important neural processes. For example, it is involved in the formation of synapses, which are the connections between neurons in the brain. It is also involved in the regulation of neurotransmitter release, which is the process by which neurons communicate with each other.

One of the most promising aspects of MTND5P31 is its potential as a drug target. By targeting this protein, researchers hope to be able to treat a wide range of neurological disorders, including Alzheimer's disease. This is becauseMTND5P31 is known to play a role in the development and progression of these disorders, and may be a useful target for drugs that are designed to treat them.

In addition to its potential as a drug target, MTND5P31 is also an important biomarker for several neurological disorders. For example, it is often used as a biomarker for Alzheimer's disease, as it is believed to be involved in the development and progression of this disorder. In addition, MTND5P31 has also been used as a biomarker for other disorders, such as Parkinson's disease and multiple sclerosis.

Overall, MTND5P31 is a protein that is known for its role in the regulation of synaptic plasticity and several important neural processes. Its unique structure and potential as a drug target make it an attractive target for researchers, and its use as a biomarker for several neurological disorders makes it an important tool for the diagnosis and treatment of these disorders.

Protein Name: MT-ND5 Pseudogene 31

The "MTND5P31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND5P31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets